2023 annual financial data
Myriad Genetics 2023 Operating margin
Direct answer
Operating margin was -19.2%.
Operating income was -144,600,000 USD and net income was -263,300,000 USD.
Operating cash flow was -110,900,000 USD.
Get free Myriad Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 753,200,000 USD
- Operating income
- -144,600,000 USD
- Net income
- -263,300,000 USD
- Operating cash flow
- -110,900,000 USD